Company

Biolinq

Rocket Ship Rating

Rocket Ship Rating: 98 out of 100

The first fully autonomous, needle-free glucose sensor

Also known as Biolinq Incorporated

Medical devices & diagnostics
Hardware

Status: Operatingas of 2026-09-18
Business model: B2C
Headquarters: San Diego, CA, United States
Customers: persons 22 years or older not on insulin
Legal name: Biolinq Incorporated

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Biolinq is a healthcare technology company pioneering precision multi-analyte wearable sensors to improve metabolic health.

Funding snapshot

Total raised: $158MSum of rounds, as of 2026-09-18Source (opens in a new tab)
Latest round: Series C, $100M2025-04-22

Funding rounds

Series C: $100M2025-04-22, Company stated
Bridge: $58M2024-04-04, Company stated
Round, 2023: $59.1M2023-12-13, SEC form D sold, 43 investors
Round, 2021: $77.9M2021-09-02, SEC form D sold, 62 investors
Round, 2021: $5.2M2021-03-16, SEC form D sold, 21 investors
Round, 2020: $3.6M2020-03-25, SEC form D sold, 17 investors
Round, 2019: $3M2019-03-13, SEC form D sold, 9 investors
Round, 2017: $8.1M2017-11-14, SEC form D sold, 17 investors
Round, 2016: $450K2016-09-16, SEC form D sold, 5 investors

Products

Hardware: Biolinq Shine
Hardware: Biolinq Shine
Web: Biolinq Shine™